CHA2DS2-VASc Score
CHA2DS2-VASc score was the strongest modifier of ICM cost-effectiveness. ICM was economically dominant for patients with CHA2DS2-VASc scores of 7 to 8. ICM was cost-effective for patients with CHA2DS2-VASc scores of 4 to 6. ICM was not cos…
1 sources - 5 claims
CHA2DS2-VASc score was the strongest modifier of ICM cost-effectiveness. ICM was economically dominant for patients with CHA2DS2-VASc scores of 7 to 8. ICM was cost-effective for patients with CHA2DS2-VASc scores of 4 to 6. ICM was not cost-effective for patients with CHA2DS2-VASc scores of 2 to 3. Baseline stroke risk was stratified using the CHA2DS2-VASc score distribution from STROKE AF, where the median score was 5.